How severe is CVE-2024-35145?

CVE-2024-35145 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2024-35145 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-35145?

CVE-2024-35145 affects Ibm Maximo Application Suite. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-35145?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-35145 have an EU (EUVD) identifier?

Yes. CVE-2024-35145 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-35548.

When was CVE-2024-35145 published?

CVE-2024-35145 was published on 2025-01-25 and last updated on 2026-06-17.

CVE-2024-35145

CVE-2024-35145 is a medium-severity vulnerability in Ibm Maximo Application Suite with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 6.1)
EPSS exploit prediction: 0% (16th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-35548
Weakness: CWE-79
Affected product: Ibm Maximo Application Suite
Published: 2025-01-25
Last modified: 2026-06-17

Description

IBM Maximo Application Suite 9.0.0 - Monitor Component is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Frequently asked questions

What is CVE-2024-35145?: IBM Maximo Application Suite 9.0.0 - Monitor Component is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
How severe is CVE-2024-35145?: CVE-2024-35145 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-35145 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-35145?: CVE-2024-35145 affects Ibm Maximo Application Suite. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-35145?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-35145 have an EU (EUVD) identifier?: Yes. CVE-2024-35145 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-35548.
When was CVE-2024-35145 published?: CVE-2024-35145 was published on 2025-01-25 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7174956

Affected products (1)

cpe:2.3:a:ibm:maximo_application_suite:9.0:*:*:*:*:*:*:*

More vulnerabilities in Ibm Maximo Application Suite

CVE-2025-36386 — Critical (CVSS 9.8): IBM Maximo Application Suite 9.0.0 through 9.0.15 and 9.1.0 through 9.1.4 could allow a remote attacker to bypass…
CVE-2024-27266 — High (CVSS 8.2): IBM Maximo Application Suite 7.6.1.3 is vulnerable to an XML External Entity Injection (XXE) attack when processing XML…
CVE-2025-2898 — High (CVSS 7.5): IBM Maximo Application Suite 9.0 could allow an attacker with some level of access to elevate their privileges due to a…
CVE-2024-22328 — High (CVSS 7.5): IBM Maximo Application Suite 8.10 and 8.11 could allow a remote attacker to traverse directories on the system. An…
CVE-2021-38924 — High (CVSS 7.5): IBM Maximo Asset Management 7.6.1.1 and 7.6.1.2 could allow a remote attacker to obtain sensitive information when a…
CVE-2021-29854 — High (CVSS 7.2): IBM Maximo Asset Management 7.6.1.1 and 7.6.1.2 is vulnerable to HTTP header injection, caused by improper validation…

All CVEs affecting Ibm Maximo Application Suite →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →